Hirschsprung disease management

🧠 Pathophysiology - No Nerves, No Go

• Core Defect: Congenital aganglionosis of the distal GI tract, primarily the colon.
• Mechanism: Arrest of craniocaudal migration of neural crest cells during weeks 5-12 of gestation.
• Result: Absence of ganglion cells in the submucosal (Meissner's) and myenteric (Auerbach's) plexuses.
• Genetics: Strongly associated with loss-of-function mutations in the RET proto-oncogene.
• Location: Always affects the rectum and extends proximally for a variable distance.

⭐ The aganglionic segment cannot relax, remaining tonically contracted. This causes a functional obstruction, leading to proximal bowel dilation.

🔍 Diagnosis - Spotting the Stuck Spot

Clinical Red Flags in Newborns:

• Failure to pass meconium within 48 hours.
• Bilious emesis.
• Progressive abdominal distension.
• 💡 "Squirt sign": Explosive release of stool/gas on digital rectal exam (DRE) is highly suggestive.

Diagnostic Pathway:

• Contrast Enema: Key initial test. Visualizes a narrow distal segment (aganglionic) and a dilated proximal colon (normally innervated), defining the "transition zone."
• Anorectal Manometry: Useful screening test. Shows failure of internal anal sphincter relaxation upon rectal balloon distension (absent RAIR).
• Rectal Suction Biopsy (Gold Standard): Definitive diagnosis. Histology shows an absence of ganglion cells in the submucosal plexus.

⭐ A full-thickness biopsy is required to assess for ganglion cells in both the submucosal (Meissner) and myenteric (Auerbach) plexuses.

✂️ Management - The Great Pull-Through

The management of Hirschsprung disease is a two-stage process: initial stabilization followed by definitive surgical correction.

---

• Initial Stabilization (Pre-operative)
  • Goal: Decompress the obstructed proximal bowel, prevent Hirschsprung-Associated Enterocolitis (HAEC) and perforation.
  • Key interventions:
    • NPO (Nil Per Os)
    • IV fluids for hydration and electrolyte correction.
    • NG decompression to relieve proximal distention.
    • Serial rectal irrigations with saline to evacuate stool.

⭐ The primary goal of initial management is to decompress the obstructed proximal bowel to prevent perforation and prepare for definitive surgery.

• Definitive Treatment: The Pull-Through
  • Surgical resection of the aganglionic segment.
  • The normal, ganglionic bowel is then "pulled through" and anastomosed to the anus.
  • Commonly performed procedures:
    • Swenson: Original full-thickness resection.
    • Soave: Endorectal pull-through (leaves a muscular cuff).
    • Duhamel: Retrorectal pull-through.

⚠️ Post-Op Perils

• Hirschsprung-Associated Enterocolitis (HAEC): The most common and life-threatening complication, occurring pre- or post-operatively. Presents as a toxic megacolon-like state.

  ⭐ HAEC manifests with fever, explosive foul-smelling diarrhea, and abdominal distension. Management is urgent: NPO, IV fluids, broad-spectrum antibiotics, and decompressive rectal irrigations.

• Anastomotic Complications:

  • Leak: Early post-op; presents with fever, abdominal pain, and signs of peritonitis.
  • Stricture: Late post-op; causes recurrent constipation and obstructive symptoms.

• Chronic Dysmotility:

  • Persistent constipation
  • Fecal incontinence/soiling

⚡ Biggest Takeaways

• Gold standard diagnosis: Rectal suction biopsy showing absent ganglion cells in the submucosal plexus.
• Contrast enema is the best initial imaging test, revealing a transition zone.
• Initial management: Bowel decompression (NG tube, rectal irrigation) and fluid resuscitation.
• Definitive treatment: Surgical resection of the aganglionic segment via a pull-through procedure.
• Most feared complication: Hirschsprung-associated enterocolitis (HAEC), which can be fatal.
• Strongly associated with Down syndrome and MEN 2A/2B.